Sarah Davidson

Astera Labs’ Nasdaq‑100 debut sparks a sharp sell‑off as investors weigh earnings volatility, memory, and AI‑stock risks, leaving the chipmaker’s share price in decline.

Fisher & Paykel Healthcare’s latest earnings show steady growth driven by high‑margin respiratory and anaesthesia products, robust pipeline, and tariff‑mitigation strategies.

Advantest’s modest rebound shows Asian tech shares are resilient, with AI demand and supply‑chain stability keeping semiconductor and chip‑equipment firms afloat.

Nordic markets stay resilient as defensive and healthcare stocks outpace tech pullback, with Demant’s analyst upgrades boosting investor confidence.

Merck’s modest stock rise on a weak day is fueled by its new Alger Russell Innovation Index spot, attractive macro‑valuation, and oncology gains – a clear value play for healthcare investors.

UBS downgrades Epiroc to Sell, boosting its target to 230¢ amid tighter margins and a weaker competitive edge, while the OMXS30 falls 1.5% in a market favoring defensive stocks over cyclical peers.

Verisk Analytics expands its supply‑chain footprint by partnering with Trucker Path to embed real‑time cargo‑theft data in navigation apps, boosting route safety and risk mitigation.

TD Cowen cuts HCA Healthcare’s target price, citing tighter margins, slower revenue growth, and a competitive, regulated market—yet remains bullish on its long‑term prospects.

Skanska lands a 3 billion‑kronor Marriott hotel deal in Cincinnati, boosting its U.S. hospitality portfolio and positioning it as a top contractor for high‑value projects.

Jiangsu Hengrui Pharmaceutical boosts investor confidence with share‑buybacks and a new postoperative pain drug, riding China’s rising innovation‑drug momentum.